Quantcast
Why Arent Pregnant Women Getting Their Flu Vaccine

Why Aren't Pregnant Women Getting Their Flu Vaccine?

Group Health Research Institute Both mother and fetus are at increased risk for complications of flu infection during pregnancy. And prenatal care providers say they’re advising women to get the flu vaccine, in line with recommendations from...

Latest FluMist Stories

2014-08-19 12:28:40

MERIDEN, Conn. and SCOTTSDALE, Ariz., Aug. 19, 2014 /PRNewswire/ -- Protein Sciences Corporation and Passport Health announced today that Flublok® influenza vaccine will be available this fall at all 230+ Passport Health locations across the United States. In addition, all employers who arrange their influenza vaccination clinics through Passport Health will be able to request Flublok. http://photos.prnewswire.com/prnvar/20140617/118909 "We created Flublok to save lives and our...

2014-08-18 16:23:33

LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Influenza A Infections-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278595/-Influenza-A-Infections-Pipeline-Insights-2014.html SUMMARYDelveInsight's," Influenza A Infections-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline...

2014-08-18 04:21:18

CYPRESS, Calif. and LONDON, Aug. 18, 2014 /PRNewswire-iReach/ -- Immune Targeting Systems (ITS), specializing in the development of novel T cell immune therapies, has been developing an exciting new T cell vaccine (Flunisyn(TM)) designed to protect humans from all strains of seasonal and pandemic influenza A. To determine the effectiveness of Flunisyn(TM) ITS produced its own live influenza challenge agent derived from the recently circulating Influenza A/California/2009 (H1N1)...

2014-08-16 23:00:48

MarketReportsOnline.com adds "Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19)" report to its research store. Dallas, Texas (PRWEB) August 16, 2014 With the advancement in technology and discovery of new products in the field of medical sciences, vaccines have gained crucial position in the pharmaceutical industry. Vaccines are considered as the most effective health intervention ever developed, saving innumerable lives. The vaccine market is growing...

2014-08-13 16:26:23

- Study Demonstrates Fluzone High-Dose Vaccine 24.2 Percent More Effective Than Standard-Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older - LYON, France, Aug. 13, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that The New England Journal of Medicine published positive results from a large-scale, multi-center efficacy trial, which found that Fluzone(®) High-Dose (Influenza Vaccine)...

2014-07-30 12:30:26

LONDON, July 30, 2014 /PRNewswire/ -- Replikins Ltd. today released new data on changes in the gene structure of the Ebola virus. Before the current outbreaks, the mean Ebola Reston gene Replikin Count (number of Replikins per 100 amino acids) between 1995 and 2002 was 1.1; the mean Replikin Count increased twofold in 2010, threefold in 2012, and sixteen-fold in 2013, thus predicting the current outbreaks in humans. In the past, this technology has been shown to be able to predict...

2014-07-29 23:09:40

The National Foundation for Infectious Diseases (NFID) has been named a 2014 ASAE Power of A Silver Award winner for 'Keeping the Nation Flu-Focused,' a public awareness campaign to encourage everyone age six months and older to be vaccinated against influenza annually. Bethesda, Maryland (PRWEB) July 29, 2014 The National Foundation for Infectious Diseases (NFID) has been named a 2014 ASAE Power of A Silver Award winner for "Keeping the Nation Flu-Focused," a public...

2014-07-25 04:21:48

BEIJING, July 25, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2014, after market close on Thursday, August 14, 2014 EDT. The Company will host a conference call prior to the market opening on Friday, August 15, 2014, at 8:00 a.m. EDT (Friday, August 15, 2014 at 8:00 p.m. China Standard Time) to review the...

2014-07-23 08:30:15

BEIJING, July 23, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention ("Beijing CDC") to be a supplier of the seasonal influenza vaccine to the citizens of Beijing for 2014. The Beijing CDC plans to order a minimum of 1.2 million doses of the seasonal flu vaccine this year from four domestic vaccine manufacturers for its...

2014-07-22 08:32:20

- Largest U.S. influenza vaccine supplier, providing broad product portfolio, will distribute at least 65 million doses to help protect people across multiple age groups against the virus this season - SWIFTWATER, Pa., July 22, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the first lots of Fluzone(®) (Influenza Vaccine) for the 2014-2015 influenza ("the flu") season have been released by the U.S. Food and Drug...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related